Basic Information
Aplagon is a clinical-stage biopharmaceutical company developing proprietary, locally acting anticoagulant products (APACs) for the management of vascular occlusion associated with vascular interventions.
Aplagon Oy
Helsinki,Uusimaa,Finland
15~50 people
January 01, 2009
--